RESUMEN
Multiple factors may influence parental vaccine hesitancy towards pediatric COVID-19 vaccines and routine childhood immunizations (RCIs). Using the United States National Immunization Survey-Child COVID Module data collected from parents/guardians of children aged 5-11 years, this cross-sectional study (1) identified the trends and prevalence estimates of parental hesitancy towards pediatric COVID-19 vaccines and RCIs, (2) examined the relationship between hesitancy towards pediatric COVID-19 vaccines and RCIs, and (3) assessed trends in parental hesitancy towards RCIs by sociodemographic characteristics and behavioral and social drivers of COVID-19 vaccination. From November 2021 to July 2022, 54,329 parents or guardians were interviewed. During this 9-month period, the proportion of parents hesitant about pediatric COVID-19 vaccines increased by 15.8 percentage points (24.8% to 40.6%). Additionally, the proportion of parents who reported RCIs hesitancy increased by 4.7 percentage points from November 2021 to May 2022 but returned to baseline by July 2022. Over nine months, parents' concerns about pediatric COVID-19 infections declined; however, parents were increasingly worried about pediatric COVID-19 vaccine safety and overall importance. Furthermore, pediatric COVID-19 vaccine hesitancy was more prevalent among parents of children who were White (43.2%) versus Black (29.3%) or Hispanic (26.9%) and those residing in rural (51.3%) compared to urban (28.9%) areas. In contrast, RCIs hesitancy was higher among parents of children who were Black (32.0%) versus Hispanic (24.5%) or White (23.6%). Pediatric COVID-19 vaccine hesitancy was 2-6 times as prevalent among parents who were RCIs hesitant compared to those who were RCIs non-hesitant. This positive correlation between parental hesitancy towards pediatric COVID-19 vaccines and RCIs was observed for all demographic and psychosocial factors for unadjusted and adjusted prevalence ratios. Parent-provider interactions should increase vaccine confidence, shape social norms, and facilitate behavior change to promote pediatric vaccination rates.
RESUMEN
INTRODUCTION: COVID-19 vaccines are safe, effective, and widely available, but many adults in the U.S. have not been vaccinated for COVID-19. This study examined the associations between behavioral and social drivers of vaccination with COVID-19 vaccine uptake in the U.S. adults and their prevalence by region. METHODS: A nationally representative sample of U.S. adults participated in a cross-sectional telephone survey in August-November 2021; the analysis was conducted in January 2022. Survey questions assessed self-reported COVID-19 vaccine initiation, demographics, and behavioral and social drivers of vaccination. RESULTS: Among the 255,763 respondents, 76% received their first dose of COVID-19 vaccine. Vaccine uptake was higher among respondents aged ≥75 years (94%), females (78%), and Asian non-Hispanic people (94%). The drivers of vaccination most strongly associated with uptake included higher anticipated regret from nonvaccination, risk perception, and confidence in vaccine safety and importance, followed by work- or school-related vaccination requirements, social norms, and provider recommendation (all p<0.05). The direction of association with uptake varied by reported level of difficulty in accessing vaccines. The prevalence of all of these behavioral and social drivers of vaccination was highest in the Northeast region and lowest in the Midwest and South. CONCLUSIONS: This nationally representative survey found that COVID-19 vaccine uptake was most strongly associated with greater anticipated regret, risk perception, and confidence in vaccine safety and importance, followed by vaccination requirements and social norms. Interventions that leverage these social and behavioral drivers of vaccination have the potential to increase COVID-19 vaccine uptake and could be considered for other vaccine introductions.
Asunto(s)
Vacunas contra la COVID-19 , COVID-19 , Adulto , Femenino , Humanos , Estados Unidos/epidemiología , Estudios Transversales , COVID-19/epidemiología , COVID-19/prevención & control , Vacunación , CogniciónRESUMEN
By the end of 2021, approximately 15% of U.S. adults remained unvaccinated against COVID-19, and vaccination initiation rates had stagnated. We used unsupervised machine learning (K-means clustering) to identify clusters of unvaccinated respondents based on Behavioral and Social Drivers (BeSD) of COVID-19 vaccination and compared these clusters to vaccinated participants to better understand social/behavioral factors of non-vaccination. The National Immunization Survey Adult COVID Module collects data on U.S. adults from September 26-December 31,2021 (n = 187,756). Among all participants, 51.6% were male, with a mean age of 61 years, and the majority were non-Hispanic White (62.2%), followed by Hispanic (17.2%), Black (11.9%), and others (8.7%). K-means clustering procedure was used to classify unvaccinated participants into three clusters based on 9 survey BeSD items, including items assessing COVID-19 risk perception, social norms, vaccine confidence, and practical issues. Among unvaccinated adults (N = 23,397), 3 clusters were identified: the "Reachable" (23%), "Less reachable" (27%), and the "Least reachable" (50%). The least reachable cluster reported the lowest concern about COVID-19, mask-wearing behavior, perceived vaccine confidence, and were more likely to be male, non-Hispanic White, with no health conditions, from rural counties, have previously had COVID-19, and have not received a COVID-19 vaccine recommendation from a healthcare provider. This study identified, described, and compared the characteristics of the three unvaccinated subgroups. Public health practitioners, healthcare providers and community leaders can use these characteristics to better tailor messaging for each sub-population. Our findings may also help inform decisionmakers exploring possible policy interventions.
Asunto(s)
Vacunas contra la COVID-19 , COVID-19 , Adulto , Masculino , Humanos , Femenino , Persona de Mediana Edad , Factores Sociales , COVID-19/epidemiología , COVID-19/prevención & control , Inmunización , Análisis por ConglomeradosRESUMEN
INTRODUCTION: Focusing on subpopulations that express the intention to receive a COVID-19 vaccination but are unvaccinated may improve the yield of COVID-19 vaccination efforts. METHODS: A nationally representative sample of 789,658 U.S. adults aged ≥18 years participated in the National Immunization Survey Adult COVID Module from May 2021 to April 2022. The survey assessed respondents' COVID-19 vaccination status and intent by demographic characteristics (age, urbanicity, educational attainment, region, insurance, income, and race/ethnicity). This study compared composition and within-group estimates of those who responded that they definitely or probably will get vaccinated or are unsure (moveable middle) from the first and last month of data collection. RESULTS: Because vaccination uptake increased over the study period, the moveable middle declined among persons aged ≥18 years. Adults aged 18-39 years and suburban residents comprised most of the moveable middle in April 2022. Groups with the largest moveable middles in April 2022 included persons with no insurance (10%), those aged 18-29 years (8%), and those with incomes below poverty (8%), followed by non-Hispanic Native Hawaiian or other Pacific Islander (7%), non-Hispanic multiple or other race (6%), non-Hispanic American Indian or Alaska Native persons (6%), non-Hispanic Black or African American persons (6%), those with below high school education (6%), those with high school education (5%), and those aged 30-39 years (5%). CONCLUSIONS: A sizable percentage of adults open to receiving COVID-19 vaccination remain in several demographic groups. Emphasizing engagement of persons who are unvaccinated in some racial/ethnic groups, aged 18-39 years, without health insurance, or with lower income may reach more persons open to vaccination.
Asunto(s)
Vacunas contra la COVID-19 , COVID-19 , Aceptación de la Atención de Salud , Adolescente , Adulto , Humanos , COVID-19/epidemiología , COVID-19/prevención & control , Vacunas contra la COVID-19/uso terapéutico , Estados Unidos/epidemiología , Vacunación/psicología , Vacunación/estadística & datos numéricos , Aceptación de la Atención de Salud/etnología , Aceptación de la Atención de Salud/psicología , Aceptación de la Atención de Salud/estadística & datos numéricosRESUMEN
INTRODUCTION: Little is known about how the drivers of COVID-19 vaccination vary across the U.S. To inform vaccination outreach efforts, this study explores geographic variation in correlates of COVID-19 nonvaccination among adults. METHODS: Participants were a nationally representative sample of U.S. adults identified through random-digit dialing for the National Immunization Survey-Adult COVID Module. Analyses examined the geographic and temporal landscape of constructs in the Behavioral and Social Drivers of Vaccination Framework among unvaccinated respondents from May 2021 to December 2021 (n=531,798) and sociodemographic and geographic disparities and Behavioral and Social Drivers of Vaccination predictors of COVID-19 nonvaccination from October 2021 to December 2021 (n=187,756). RESULTS: National coverage with at least 1 dose of COVID-19 vaccine was 79.3% by December 2021, with substantial geographic heterogeneity. Regions with the largest proportion of unvaccinated persons who would probably get a COVID-19 vaccine or were unsure resided in the Southeast and Midwest (Health and Human Services Regions 4 and 5). Both regions had similar temporal trends regarding concerns about COVID-19 and confidence in vaccine importance, although the Southeast had especially low confidence in vaccine safety in December 2021, lowest in Florida (5.5%) and highest in North Carolina (18.0%). The strongest Behavioral and Social Drivers of Vaccination correlate of not receiving a COVID-19 vaccination was lower confidence in COVID-19 vaccine importance (adjusted prevalence ratio=5.19, 95% CI=4.93, 5.47; strongest in the Northeast, Southwest, and Mountain West and weakest in the Southeast and Midwest). Other Behavioral and Social Drivers of Vaccination correlates also varied by region. CONCLUSIONS: Contributors to nonvaccination showed substantial geographic heterogeneity. Strategies to improve COVID-19 vaccination uptake may need to be tailored regionally.
Asunto(s)
COVID-19 , Vacunas contra Papillomavirus , Humanos , Adulto , Vacunas contra la COVID-19 , COVID-19/epidemiología , COVID-19/prevención & control , Vacunación , Aceptación de la Atención de SaludRESUMEN
Antibiotic resistance is a global concern, although it has been studied most extensively in developed countries. We studied Escherichia coli and class 1 integrons in western Uganda by analyzing 1,685 isolates from people, domestic animals, and wild nonhuman primates near two national parks. Overall, 499 isolates (29.6%) were resistant to at least one of 11 antibiotics tested. The frequency of resistance reached 20.3% of isolates for trimethoprim-sulfamethoxazole but was nearly zero for the less commonly available antibiotics ciprofloxacin (0.4%), gentamicin (0.2%), and ceftiofur (0.1%). The frequency of resistance was 57.4% in isolates from people, 19.5% in isolates from domestic animals, and 16.3% in isolates from wild nonhuman primates. Isolates of livestock and primate origin displayed multidrug resistance patterns identical to those of human-origin isolates. The percentage of resistant isolates in people was higher near Kibale National Park (64.3%) than near Bwindi Impenetrable National Park (34.6%), perhaps reflecting local socioeconomic or ecological conditions. Across antibiotics, resistance correlated negatively with the local price of the antibiotic, with the most expensive antibiotics (nalidixic acid and ciprofloxacin) showing near-zero resistance. Among phenotypically resistant isolates, 33.2% harbored class 1 integrons containing 11 common resistance genes arranged into nine distinct gene cassettes, five of which were present in isolates from multiple host species. Overall, these results show that phenotypic resistance and class 1 integrons are distributed broadly among E. coli isolates from different host species in this region, where local socioeconomic and ecological conditions may facilitate widespread diffusion of bacteria or resistance-conferring genetic elements.IMPORTANCE Antibiotic resistance is a global problem. This study, conducted in rural western Uganda, describes antibiotic resistance patterns in Escherichia coli bacteria near two forested national parks. Resistance was present not only in people, but also in their livestock and in nearby wild nonhuman primates. Multidrug resistance and class 1 integrons containing genes that confer resistance were common and were similar in people and animals. The percentage of resistant isolates decreased with increasing local price of the antibiotic. Antibiotic resistance in this setting likely reflects environmental diffusion of bacteria or their genes, perhaps facilitated by local ecological and socioeconomic conditions.
Asunto(s)
Animales Domésticos/microbiología , Antibacterianos/farmacología , Farmacorresistencia Bacteriana , Infecciones por Escherichia coli/microbiología , Infecciones por Escherichia coli/veterinaria , Escherichia coli/efectos de los fármacos , Integrones , Primates/microbiología , Ampicilina/farmacología , Animales , Animales Salvajes , Escherichia coli/clasificación , Escherichia coli/genética , Escherichia coli/aislamiento & purificación , Heces/microbiología , Humanos , Ganado/microbiología , Pruebas de Sensibilidad Microbiana , Estreptomicina/farmacología , Combinación Trimetoprim y Sulfametoxazol/farmacología , UgandaRESUMEN
OBJECTIVE: In March 2016, the state health departments of Wisconsin and Minnesota learned of three shipyard workers with blood lead levels (BLLs) more than 40âµg/dL. An investigation was conducted to determine the extent of and risk factors for the exposure. METHODS: We defined a case as an elevated BLL more than or equal to 5âµg/dL in a shipyard worker. Workers were interviewed regarding their symptoms and personal protective equipment (PPE) use. RESULTS: Of 357 workers, 65.0% had received more than or equal to 1 BLL test. Among tested workers, 171 (73.7%) had BLLmax more than or equal to 5âµg/dL. Workers who received respirator training or fit testing had a median BLLmax of 18.0âµg/dL, similar to the median BLLmax of workers who did not receive such training (22.6âµg/dL, Pâ=â0.20). CONCLUSIONS: Our findings emphasize the importance of adequate provision and use of PPE to prevent occupational lead exposure.
Asunto(s)
Exposición por Inhalación/análisis , Plomo/sangre , Exposición Profesional/análisis , Dispositivos de Protección Respiratoria/estadística & datos numéricos , Navíos , Adulto , Artralgia/epidemiología , Ingestión de Alimentos , Fatiga/epidemiología , Femenino , Higiene de las Manos , Conocimientos, Actitudes y Práctica en Salud , Humanos , Masculino , Persona de Mediana Edad , Mialgia/epidemiología , Exposición Profesional/prevención & control , Ocupaciones , Factores de Riesgo , Fumar , WisconsinRESUMEN
A man aged 30â years presented to an emergency department with a 1â month history of severe abdominal pain, jaundice, constipation, lower extremity weakness and weight loss. A peripheral blood smear was performed that showed basophilic stippling of erythrocytes prompting a blood lead level (BLL) evaluation. The patient had a BLL of >200â µg/dL. Retained bullet fragments were identified in the left lower extremity from a previous gunshot wound 10â years prior. Lead from the excised bullet fragment was consistent with the patient's blood lead by isotope ratio analysis. This case is a rare example of a severely elevated BLL attributed to bullet fragments in soft tissue. Bullets retained in soft tissue are not often considered a risk factor for a markedly elevated BLL because they become encapsulated within the tissue over time.
Asunto(s)
Cuerpos Extraños/diagnóstico por imagen , Intoxicación por Plomo/sangre , Heridas por Arma de Fuego/complicaciones , Adulto , Manejo de la Enfermedad , Cuerpos Extraños/complicaciones , Humanos , Intoxicación por Plomo/etiología , MasculinoRESUMEN
An estimated 115,000 firearm injuries occur annually in the United States, and approximately 70% are nonfatal (1). Retained bullet fragments (RBFs) are an infrequently reported, but important, cause of lead toxicity; symptoms are often nonspecific and can appear years after suffering a gunshot wound (2,3). Adult blood lead level (BLL) screening is most commonly indicated for monitoring of occupational lead exposure; routine testing of adults with RBFs is infrequent (3). States collaborate with CDC's National Institute for Occupational Safety and Health (NIOSH) to monitor elevated BLLs through the Adult Blood Lead Epidemiology and Surveillance (ABLES) program (4,5). To help assess the public health burden of RBFs, data for persons with BLLs ≥10 µg/dL reported to ABLES during 2003-2012 were analyzed. An RBF-associated case was defined as a BLL ≥10 µg/dL in a person with an RBF. A non-RBF-associated case was defined as a BLL ≥10 µg/dL without an RBF. During 2003-2012, a total of 145,811 persons aged ≥16 years with BLLs ≥10 µg/dL were reported to ABLES in 41 states. Among these, 457 RBF-associated cases were identified with a maximum RBF-associated BLL of 306 µg/dL. RBF-associated cases accounted for 0.3% of all BLLs ≥10 µg/dL and 4.9% of BLLs ≥80 µg/dL. Elevated BLLs associated with RBFs occurred primarily among young adult males in nonoccupational settings. Low levels of suspicion of lead toxicity from RBFs by medical providers might cause a delay in diagnosis (3). Health care providers should inquire about an RBF as the potential cause for lead toxicity in an adult with an elevated BLL whose lead exposure is undetermined.
Asunto(s)
Cuerpos Extraños/complicaciones , Intoxicación por Plomo/etiología , Plomo/sangre , Heridas por Arma de Fuego/complicaciones , Adolescente , Adulto , Anciano , Femenino , Humanos , Intoxicación por Plomo/epidemiología , Masculino , Persona de Mediana Edad , Estados Unidos/epidemiología , Adulto JovenRESUMEN
Exposure to the neurotoxic element lead (Pb) continues to be a major human health concern, particularly for children in US urban settings, and the need for robust tools for assessment of exposure sources has never been greater. The latest generation of multicollector inductively coupled plasma mass spectrometry (MC-ICPMS) instrumentation offers the capability of using Pb isotopic signatures as a tool for environmental source tracking in public health. We present a case where MC-ICPMS was applied to isotopically resolve Pb sources in human clinical samples. An adult male and his child residing in Milwaukee, Wisconsin, presented to care in August 2015 with elevated blood lead levels (BLLs) (>200 µg/dL for the adult and 10 µg/dL for the child). The adult subject is a gunshot victim who had multiple bullet fragments embedded in soft tissue of his thigh for approximately 10 years. This study compared the high-precision isotopic fingerprints (<1 2σ external precision) of Pb in the adult's and child's whole blood (WB) to the following possible Pb sources: a surgically extracted bullet fragment, household paint samples and tap water, and a Pb water-distribution pipe removed from servicing a house in the same neighborhood. Pb in the bullet and adult WB were nearly isotopically indistinguishable (matching within 0.05-0.56 ), indicating that bullet fragments embedded in soft tissue could be the cause of both acute and chronic elevated blood Pb levels. Among other sources investigated, no single source dominated the child's exposure profile as reflected in the elevated BLL.
Asunto(s)
Radioisótopos de Plomo/sangre , Plomo/sangre , Heridas por Arma de Fuego/sangre , Adulto , Niño , Humanos , Masculino , WisconsinRESUMEN
BACKGROUND: E-cigarettes are battery-powered devices that deliver nicotine and flavorings by aerosol and have been marketed in the United States since 2007. Because e-cigarettes have increased in popularity, toxicity potential from device misuse and malfunction also has increased. National data indicate that during 20102014, exposure calls to US poison control centers increased only 0.3% for conventional cigarette exposures, whereas calls increased 41.7% for e-cigarette exposures. METHODS: We characterized cigarette and e-cigarette exposure calls to the Wisconsin Poison Center January 1, 2010 through October 10, 2015. We compared cigarette and e-cigarette exposure calls by exposure year, demographic characteristics, caller site, exposure site, exposure route, exposure reason, medical outcome, management site, and level of care at a health care facility. RESULTS: During January 2010 to October 2015, a total of 98 e-cigarette exposure calls were reported, and annual exposure calls increased approximately 17-fold, from 2 to 35. During the same period, 671 single-exposure cigarette calls with stable annual call volumes were reported. E-cigarette exposure calls were associated with children aged ≤5 years (57/98, 58.2%) and adults aged ≥20 years (30/98, 30.6%). Cigarette exposure calls predominated among children aged ≤5 years (643/671, 95.8%). CONCLUSION: The frequency of e-cigarette exposure calls to the Wisconsin Poison Center has increased and is highest among children aged ≤5 years and adults. Strategies are warranted to prevent future poisonings from these devices, including nicotine warning labels and public advisories to keep e-cigarettes away from children.
Asunto(s)
Sistemas Electrónicos de Liberación de Nicotina , Centros de Control de Intoxicaciones/estadística & datos numéricos , Adolescente , Adulto , Niño , Preescolar , Femenino , Humanos , Lactante , Masculino , Estudios Retrospectivos , WisconsinRESUMEN
CONTEXT: Age-related pharmacokinetic and pharmacodynamic changes have been extensively documented, and several concurrent diseases may underlie multiple drug therapy in the elderly. As a result, the risk of adverse drug reactions and drug interactions increases among aged patients. However, only a few studies have compared the prescribing patterns for different age groups of hospitalized patients or have evaluated the effect of age on drug prescription. OBJECTIVE: To compare the prevalence of drug prescriptions for elderly inpatients, with those for non-elderly inpatients, in order to assess age-related differences in the number of prescribed drugs, drug choices and prescribed doses, and to evaluate the prescription appropriateness for the elderly patients. TYPE OF STUDY: Cross-sectional survey. SETTING: 400-bed tertiary care general teaching hospital. PARTICIPANTS: All inpatients on one day of June 1995, except for the Intensive Care Unit and for the Departments of Psychiatry, Pediatrics and Obstetrics and Gynecology. PROCEDURES: All medicines prescribed to the eligible patients on the study day were recorded from the prescription sheets provided by the hospital pharmacy. MAIN MEASUREMENTS: Name, therapeutic class, and mean daily dose of the prescribed drugs. RESULTS: Of the 273 eligible inpatients, 46.5% were 14-44 years old, 33% were 45-64 years old and 20.5% were > 64 years old. Cancer was significantly more frequent among the elderly. The mean number of prescribed drugs was five for all age groups. The five most prescribed drugs for all patients were dipyrone, ranitidine, dipyrone in a fixed-dose combination, metoclopramide and cefazolin. The elderly had significantly more prescriptions for insulin, furosemide and enoxaparin. For most drugs, the mean prescribed dose showed that there was no dose adjustment for elderly patients, and drug choices for this age group were sometimes questionable. CONCLUSIONS: There was little variation in the prescribing patterns for the elderly when compared with the other age strata.
Asunto(s)
Anciano , Prescripciones de Medicamentos/estadística & datos numéricos , Pacientes Internos , Adolescente , Adulto , Distribución por Edad , Estudios Transversales , Femenino , Hospitales de Enseñanza , Humanos , Masculino , Persona de Mediana EdadRESUMEN
CONTEXTO: As alterações farmacocinéticas e farmacodinâmicas associadas ao envelhecimento têm sido amplamente documentadas, bem como o freqüente uso simultâneo de vários medicamentos como conseqüência da elevada prevalência de doenças crônico-degenerativas entre os idosos. Conseqüentemente, o risco de reações adversas a medicamentos e de interações medicamentosas aumenta em idosos. Entretanto, poucos estudos têm comparado os padrões de prescrição para diferentes grupos etários de pacientes hospitalizados ou avaliaram os efeitos da idade na prescrição de medicamentos. OBJETIVO: Comparar a prevalência de prescrição de medicamentos para pacientes idosos e não-idosos em um hospital geral universitário a fim de avaliar se existem diferenças relacionadas à idade quanto ao número de medicamentos prescritos, quanto à escolha dos medicamentos e quanto às doses prescritas, bem como a adequação da prescrição para os pacientes idosos. TIPO DE ESTUDO: Estudo observacional, do tipo transversal. LOCAL: Hospital-escola, de complexidade terciária, com 400 leitos. AMOSTRA: Todos os pacientes internados em um dia do mês de junho de 1995, excluindo os internados na Unidade de Terapia Intensiva e dos Departamentos de Psiquiatria, Pediatria, Ginecologia e Obstetrícia. PROCEDIMENTO: Todos os medicamentos prescritos para os pacientes adultos internados nas enfermarias incluídas no estudo foram registrados a partir da folha de prescrição fornecida pela farmácia hospitalar. Os dados demográficos e os diagnósticos de alta foram fornecidos pelo Departamento de Estatística do Hospital. As informações sobre o peso e exames laboratoriais dos pacientes idosos foram obtidas a partir dos prontuários médicos. VARIAVEIS ESTUDADAS: Características demográficas dos pacientes, diagnósticos de alta, exames laboratoriais (somente para os idosos) e medicamentos prescritos (nome, classe terapêutica, dose média diária). RESULTADOS: Entre os 273 pacientes internados e elegíveis para os estudo, 46,5% encontravam-se na faixa etária de 14-44 anos; 33%, de 45-64 anos e 20,5%, na faixa etária > 64 anos. Neoplasias foram significantemente mais freqüentes entre os pacientes idosos. A média do número de medicamentos prescritos foi de cinco por paciente para os três grupos etários. No conjunto dos pacientes os cinco medicamentos mais prescritos foram: dipirona, ranitidina, dipirona em combinação dose-fixa, metoclopramida e cefazolina. Os pacientes idosos receberam significantemente mais...
Asunto(s)
Humanos , Masculino , Femenino , Adolescente , Adulto , Persona de Mediana Edad , Prescripciones de Medicamentos , Anciano , Pacientes Internos , Distribución por Edad , Estudios Transversales , Hospitales de EnseñanzaRESUMEN
OBJETIVO: Documentar a incidência e a epidemiologia descritiva de meningites bacterianas entre pessoas com idade inferior a 20 anos em uma região geográfica definida do Brasil. O período foi de dois anos, imediatamente anterior à introdução da vacina contra Haemophilus influenzae tipo b (Hib), no Programa Nacional de Imunização do Brasil. MÉTODOS: Estudo epidemiológico populacional dos casos de meningites bacterianas notificados entre residentes em Campinas, SP, Brasil, com idade inferior a 20 anos (n=316.570), entre 1997 e 1998. Baseia-se em dados de notificação da vigilância epidemiológica da Secretaria Municipal de Saúde de Campinas, relatados entre casos provenientes de pacientes hospitalizados, atendimento em pronto-socorros, certificados de óbito, autópsias ou atendimentos em ambulatórios. RESULTADOS: A incidência de meningites bacterianas (n=274) foi de 334,9; 115 e 43,5 casos por 105 pessoas-ano entre residentes, em Campinas, com idade inferior a 1,5 e 20 anos, respectivamente. Em todos os casos houve hospitalização com uma média de permanência no hospital de 12 dias. O uso prévio de antimicrobianos notificado foi de 4,0 por cento. A taxa de mortalidade total devida a meningites bacterianas entre pessoas com idade inferior a 20 anos foi de 9 por cento (24/274), com 75 por cento das mortes ocorrendo entre crianças com idade inferior a 5 anos. A incidência de meningites causadas por Haemophilus influenzae tipo b (Hib) (n=26) foi de 62,8 e 17 casos por 105 pessoas-ano em crianças com idade inferior a 1 e 5 anos, respectivamente. CONCLUSÕES: A incidência e a epidemiologia descritiva de meningites causadas por Haemophilus influenzae tipo b (Hib), entre crianças com idade inferior a 5 anos, em Campinas, SP, Brasil, durante o período de 1997 a 1998, foram semelhantes às relatadas pelos Estados Unidos, Europa Ocidental e Israel no período anterior ao extenso uso da vacina contra o Haemophilus influenzae tipo b nessas regiões. O estudo fornece valores de referência para outras pesquisas posteriores que avaliem mudanças na etiologia e na incidência de meningites bacterianas em crianças, depois da introdução de vacinação rotineira contra Haemophilus influenzae tipo b, no Brasil